Tocilizumab for multirefractory adult-onset Still's disease

被引：57

作者：

De Bandt, M. ^{[1
]}

Saint-Marcoux, B. ^{[1
]}

机构：

[1] R Ballanger Hosp, Rheumatol Unit, F-93600 Aulnay Sous Bois, France

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2009年 / 68卷 / 01期

关键词：

JUVENILE IDIOPATHIC ARTHRITIS; RHEUMATOID-ARTHRITIS; ANTIBODY; TRIAL;

D O I：

10.1136/ard.2008.088179

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

收藏

页码：153 / 154

页数：4

相关论文

共 10 条

[1]

Successful treatment of refractory adult onset Still's disease with rituximab [J].

Ahmadi-Simab, K. ;

Lamprecht, P. ;

Jankowiak, C. ;

Gross, W. L. .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (08) :1117-1118

[2]

Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? [J].

Efthimiou, Petros ;

Kontzias, Apostolos ;

Ward, Carla M. ;

Ogden, Neeta S. .

NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (06) :328-335

[3]

Tumour necrosis factor a blocking agents in refractory adult Still's disease: an observational study of 20 cases [J].

Fautrel, B ;

Sibilia, J ;

Mariette, X ;

Combe, B .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) :262-266

[4]

GENOVESE M, 2007, ARTHRITIS RHEUM S9, V56

[5]

Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease:: preliminary experience in France [J].

Lequerre, T. ;

Quartier, P. ;

Rosellini, D. ;

Alaoui, F. ;

De Bandt, M. ;

Mejjad, O. ;

Kone-Paut, I. ;

Michel, M. ;

Dernis, E. ;

Khellaf, M. ;

Limal, N. ;

Job-Deslandre, C. ;

Fautrel, B. ;

Le Loet, X. ;

Sibilia, J. .

ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) :302-308

[6]

Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): Evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab [J].

Nishimoto, Norihiro ;

Hashimoto, Jun ;

Miyasaka, Nobuyuki ;

Yamamoto, Kazuhiko ;

Kawai, Shinichi ;

Takeuchi, Tsutomu ;

Murata, Norikazu ;

van der Heijde, Desiree ;

Kishimoto, Tadamitsu .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (09) :1162-1167

[7]

Recent advances in immunopathophysiology of interleukin-6: An innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interieukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases [J].

Ohsugi, Yoshiyuki .

BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (11) :2001-2006

[8]

Adult Still's disease reflects a Th2 rather than a Thl cytokine profile [J].

Saiki, O ;

Uda, H ;

Nishimoto, N ;

Miwa, T ;

Mima, T ;

Ogawara, T ;

Azuma, N ;

Katada, Y ;

Sawaki, J ;

Tsutsui, H ;

Matsui, K ;

Maeda, A ;

Nakanishi, K .

CLINICAL IMMUNOLOGY, 2004, 112 (01) :120-125

[9]

Smolen J, 2007, ANN RHEUM DIS, V66, P87

[10]

Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement [J].

Woo, P ;

Wilkinson, N ;

Prieur, AM ;

Southwood, T ;

Leone, V ;

Livermore, P ;

Wythe, H ;

Thomson, D ;

Kishimoto, T .

ARTHRITIS RESEARCH & THERAPY, 2005, 7 (06) :R1281-R1288